FDA approves over-the-counter combo of Tylenol and Naproxen for pain relief

The Food and Drug Administration has granted approval for a new over-the-counter medication that combines acetaminophen and naproxen sodium. This development marks the first time these two common pain relievers have been combined into a single, fixed-dose tablet available without a prescription.

The new product is formulated for adults and children 12 years of age and older. It is intended for the temporary relief of minor aches and pains resulting from various conditions, including headaches, backaches, muscular aches, toothaches, menstrual cramps, and minor arthritis pain. By integrating these two substances into one tablet, the medication aims to provide up to 12 hours of pain relief per dose.

Acetaminophen and naproxen are among the most frequently used pain relievers in the United States. This regulatory approval supports federal efforts to increase consumer access to verified, safe non-prescription medication options. The combination is explicitly opioid-free, serving as an additional tool for pain management for patients.

While the FDA has finalized its approval, details regarding the specific retail timeline are pending. Consumers can expect the product to appear on pharmacy shelves soon. This shift represents a practical change in how individuals can manage everyday pain at home.